MIND was a prospective, open-label trial that enrolled adults up to 80 years old with moderate-large (20-80 mL) ...

The GLP-1 receptor agonist exenatide failed to meet its primary outcome in a phase III trial of Parkinson's disease patients.

Garner is a behavioral intervention scientist and an assistant professor of nutritional sciences.

The balance remaining in that 4-year grant, which began in June of 2022 -- $743,706 -- was stripped from their account ...

Shanon and William Schmidtknecht, of Poynette, filed their lawsuit in federal court in Milwaukee on Jan. 21, a year to the ...

Dairy cattle in Nevada have been infected with a new type of bird flu that's different from the version that has spread in ...

Elon Musk's Department of Government Efficiency (DOGE) team targeted several federal health agencies, sending representatives ...

An artificial intelligence (AI)-enabled hand sensor delivering closed-loop haptic feedback appeared to be an effective ...

The CDC's Morbidity and Mortality Weekly Report ( MMWR) resumed publishing after an unprecedented 2-week hiatus, but without the three H5N1 avian influenza papers that were slated to publish on Jan.

In an editorial, J. Mocco, MD, of Mount Sinai Health System in New York City, characterized the DISTAL and ESCAPE-MeVO ...

Despite efforts to curb overdiagnosis of thyroid cancer, the issue has continued to plague U.S. healthcare, according to ...

Former MetroHealth CEO Airica Steed, MD, sued the Cleveland-area hospital system, accusing it of discrimination, harassment, and a toxic work environment. ( WKYC) ...